Parmax Pharma has clarified that the Company is regularly sharing all the information relating to its operation / performance including any other price sensitive information with the stock exchange from time to time as required under Regulation 30 of SEBI (listing Obligations and Disclosure Requirements) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.